CJC-1295 without DAC provides shorter-acting growth hormone release, allowing for more natural pulsatile secretion patterns in research studies.
CJC-1295 without DAC is a modified GHRH analogue that maintains natural pulsatile growth hormone release patterns. Without the Drug Affinity Complex, this peptide has a shorter half-life, allowing for more physiological GH secretion rhythms. Researchers study it for its effects on natural GH pulsatility and circadian hormone patterns.
Research on CJC-1295 without DAC focuses on its effects on pulsatile growth hormone secretion and natural GH rhythms. Studies examine its influence on GH pulse amplitude, frequency, and circadian patterns. Researchers investigate how it affects sleep-related GH secretion, IGF-1 production, and metabolic processes while maintaining physiological hormone pulsatility in laboratory models.
For laboratory research purposes only. Not for human consumption or clinical use. This product is intended solely for in-vitro research and educational applications.

Explore similar peptides and compounds that researchers often study together